These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 15488341)
21. Characterization of anxiety-related responses in male rats following prolonged exposure to therapeutic doses of oral methylphenidate. Britton GB; Bethancourt JA Pharmacol Biochem Behav; 2009 Oct; 93(4):451-9. PubMed ID: 19540871 [TBL] [Abstract][Full Text] [Related]
22. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434 [TBL] [Abstract][Full Text] [Related]
23. Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes. Müller U; Suckling J; Zelaya F; Honey G; Faessel H; Williams SC; Routledge C; Brown J; Robbins TW; Bullmore ET Psychopharmacology (Berl); 2005 Aug; 180(4):624-33. PubMed ID: 15830222 [TBL] [Abstract][Full Text] [Related]
24. A study paradigm allowing comparison of multiple high-resolution rCBV-maps for the examination of drug effects. Rausch M; Gentsch C; Enz A; Baumann D; Rudin M NMR Biomed; 2005 Jun; 18(4):260-8. PubMed ID: 15759291 [TBL] [Abstract][Full Text] [Related]
30. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biederman J; Mick E; Surman C; Doyle R; Hammerness P; Harpold T; Dunkel S; Dougherty M; Aleardi M; Spencer T Biol Psychiatry; 2006 May; 59(9):829-35. PubMed ID: 16373066 [TBL] [Abstract][Full Text] [Related]
31. Methylphenidate increases creatine kinase activity in the brain of young and adult rats. Scaini G; Fagundes AO; Rezin GT; Gomes KM; Zugno AI; Quevedo J; Streck EL Life Sci; 2008 Dec; 83(23-24):795-800. PubMed ID: 18938183 [TBL] [Abstract][Full Text] [Related]
32. Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults. Reiz JL; Donnelly GA; Michalko K Clin Ther; 2008 Jan; 30(1):59-69. PubMed ID: 18343243 [TBL] [Abstract][Full Text] [Related]
33. Different adaptations in ventral tegmental area dopamine neurons in control and ethanol exposed rats after methylphenidate treatment. Shen RY; Choong KC Biol Psychiatry; 2006 Apr; 59(7):635-42. PubMed ID: 16199009 [TBL] [Abstract][Full Text] [Related]
34. Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats. Drouin C; Page M; Waterhouse B J Neurophysiol; 2006 Aug; 96(2):622-32. PubMed ID: 16687613 [TBL] [Abstract][Full Text] [Related]
35. Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality. Zang YF; Jin Z; Weng XC; Zhang L; Zeng YW; Yang L; Wang YF; Seidman LJ; Faraone SV Brain Dev; 2005 Dec; 27(8):544-50. PubMed ID: 15876503 [TBL] [Abstract][Full Text] [Related]
36. Neurophysiological actions of methylphenidate in the primary somatosensory cortex. Drouin C; Wang D; Waterhouse BD Synapse; 2007 Dec; 61(12):985-90. PubMed ID: 17854047 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma. Volkow ND; Wang GJ; Fowler JS; Molina PE; Logan J; Gatley SJ; Gifford A; Ding YS; Wong C; Pappas NR; Zhu W; Swanson JM Psychopharmacology (Berl); 2003 Mar; 166(3):264-70. PubMed ID: 12589522 [TBL] [Abstract][Full Text] [Related]
38. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains. Rhodes SM; Coghill DR; Matthews K J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758 [TBL] [Abstract][Full Text] [Related]
39. Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? Markowitz JS; Patrick KS J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S54-61. PubMed ID: 18480678 [TBL] [Abstract][Full Text] [Related]
40. Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach. Marquand AF; O'Daly OG; De Simoni S; Alsop DC; Maguire RP; Williams SC; Zelaya FO; Mehta MA Neuroimage; 2012 Apr; 60(2):1015-24. PubMed ID: 22266414 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]